BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14550813)

  • 21. Soluble recombinant CMVpp65 spanning multiple HLA alleles for reconstitution of antiviral CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation.
    Paine A; Oelke M; Tischer S; Heuft HG; Blasczyk R; Eiz-Vesper B
    J Immunother; 2010 Jan; 33(1):60-72. PubMed ID: 19952955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of T cell epitopes by the use of rapidly generated mRNA fragments.
    Britten CM; Meyer RG; Graf C; Huber C; Wölfel T
    J Immunol Methods; 2005 Apr; 299(1-2):165-75. PubMed ID: 15914199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells.
    Abu-Khader A; Krause S
    Eur J Haematol; 2013 Dec; 91(6):534-45. PubMed ID: 23952609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of transgenic HLA A*0201/Kb and HHD II mice to evaluate frequency of cytomegalovirus IE1-derived peptide usage in eliciting human CD8 cytokine response.
    Gallez-Hawkins G; Villacres MC; Li X; Sanborn MC; Lomeli NA; Zaia JA
    J Virol; 2003 Apr; 77(7):4457-62. PubMed ID: 12634406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple and efficient method of generating HCMV pp65-specific T cells using overlapping peptides.
    Hwang SU; Lee JH; Choi SY; Lee YT; Park SY; Lee HS; Jae JW; Jung NC; Wang Y; Lim DS
    Acta Virol; 2020; 64(4):470-479. PubMed ID: 33151741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects.
    Slezak SL; Bettinotti M; Selleri S; Adams S; Marincola FM; Stroncek DF
    J Transl Med; 2007 Mar; 5():17. PubMed ID: 17391521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of HLA-A*2402-restricted HCMV immediate early-1 (IE-1) epitopes as targets for CD8+ HCMV-specific cytotoxic T lymphocytes.
    Lim JB; Kim HO; Jeong SH; Ha JE; Jang S; Lee SG; Lee K; Stroncek D
    J Transl Med; 2009 Aug; 7():72. PubMed ID: 19698161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of HLA-A24-restricted CTL epitope encoded by the matrix protein pp65 of human cytomegalovirus.
    Akiyama Y; Maruyama K; Mochizuki T; Sasaki K; Takaue Y; Yamaguchi K
    Immunol Lett; 2002 Aug; 83(1):21-30. PubMed ID: 12057851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2.
    Braendstrup P; Mortensen BK; Justesen S; Osterby T; Rasmussen M; Hansen AM; Christiansen CB; Hansen MB; Nielsen M; Vindeløv L; Buus S; Stryhn A
    PLoS One; 2014; 9(4):e94892. PubMed ID: 24760079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
    Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
    Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of immune dominant cytomegalovirus epitopes using quantitative real-time polymerase chain reactions to measure interferon-gamma production by peptide-stimulated peripheral blood mononuclear cells.
    Provenzano M; Mocellin S; Bettinotti M; Preuss J; Monsurrò V; Marincola FM; Stroncek D
    J Immunother; 2002; 25(4):342-51. PubMed ID: 12142557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and expansion of human cytomegalovirus- specific cytotoxic T lymphocytes using interferon-gamma secretion assay.
    Bissinger AL; Rauser G; Hebart H; Frank F; Jahn G; Einsele H
    Exp Hematol; 2002 Oct; 30(10):1178-84. PubMed ID: 12384149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.
    Keever-Taylor CA; Margolis D; Konings S; Sandford GR; Nicolette CA; Lawendowski C; Burns WH
    Biol Blood Marrow Transplant; 2001; 7(5):247-56. PubMed ID: 11400946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles.
    Lacey SF; Villacres MC; La Rosa C; Wang Z; Longmate J; Martinez J; Brewer JC; Mekhoubad S; Maas R; Leedom JM; Forman SJ; Zaia JA; Diamond DJ
    Hum Immunol; 2003 Apr; 64(4):440-52. PubMed ID: 12651070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation.
    Sacre K; Nguyen S; Deback C; Carcelain G; Vernant JP; Leblond V; Autran B; Dhedin N
    J Virol; 2008 Oct; 82(20):10143-52. PubMed ID: 18684826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunodominant CD8 T cell response to the human cytomegalovirus tegument phosphoprotein pp65(495-503) epitope critically depends on CD4 T cell help in vaccinated HLA-A*0201 transgenic mice.
    Reiser M; Wieland A; Plachter B; Mertens T; Greiner J; Schirmbeck R
    J Immunol; 2011 Sep; 187(5):2172-80. PubMed ID: 21810614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway.
    Lautscham G; Mayrhofer S; Taylor G; Haigh T; Leese A; Rickinson A; Blake N
    J Exp Med; 2001 Oct; 194(8):1053-68. PubMed ID: 11602636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IE1-pp65 recombinant protein from human CMV combined with a nanoparticulate carrier, SMBV, as a potential source for the development of anti-human CMV adoptive immunotherapy.
    Vaz-Santiago J; Lulé J; Rohrlich P; Kravtzoff R; Le Roy E; Davignon JL; Betbeder D; Davrinche C
    Cytotherapy; 2002; 4(1):11-9. PubMed ID: 11953037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma.
    Ayyoub M; Stevanovic S; Sahin U; Guillaume P; Servis C; Rimoldi D; Valmori D; Romero P; Cerottini JC; Rammensee HG; Pfreundschuh M; Speiser D; Lévy F
    J Immunol; 2002 Feb; 168(4):1717-22. PubMed ID: 11823502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.